- Home
- NSRX vs GNS Comparison
NSRX vs GNS Comparison
Compare NSRX & GNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NSRX | GNS |
|---|---|---|
| Founded | 2019 | 2002 |
| Country | Israel | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.1M | 32.1M |
| IPO Year | 2024 | 2021 |
Fundamental Metrics
Financial Performance| Metric | NSRX | GNS |
|---|---|---|
| Price | $2.87 | $0.10 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $16.50 | N/A |
| AVG Volume (30 Days) | 15.0K | ★ 2.4M |
| Earning Date | 08-17-2026 | 09-28-2026 |
| Dividend Yield | N/A | ★ 194.74% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $127.02 |
| Revenue Next Year | N/A | $36.19 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.98 | $0.11 |
| 52 Week High | $9.50 | $1.06 |
Technical Indicators
Market Signals| Indicator | NSRX | GNS |
|---|---|---|
| Relative Strength Index (RSI) | 38.74 | 31.26 |
| Support Level | $2.98 | N/A |
| Resistance Level | $3.61 | $0.14 |
| Average True Range (ATR) | 0.30 | 0.01 |
| MACD | -0.03 | -0.00 |
| Stochastic Oscillator | 26.14 | 32.36 |
Price Performance
Historical ComparisonAbout NSRX Nasus Pharma Ltd. Ordinary Shares
Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.
About GNS Genius Group Limited
Genius Group Ltd is an Edtech and education company that provides entrepreneur education system business development tools and management consultancy services to entrepreneurs and entrepreneur resorts. Its revenue is derived from five reportable segments: Central, Academy, School, Resorts, and Discontinued operations. Geographically, it operates in Europe/Middle East/Africa, Asia/Pacific, and North America/South America.